Well, it didn’t take Michael Robinson long to alight on a new letter — the former editor of American Wealth Underground left his publisher and newsletter a while back (don’t know why, or if it was voluntary) and has now moved to Money Map Press. Both publishers (his old one was Insiders Strategy Group) are [...]
Patrick Cox is not a shy guy. I don’t think I’ve ever read one of his biotech teaser ads that didn’t leave me convinced (at least for a moment) that the world was about to be changed because of the newest potion or pill that his favorite little companies were developing. And this latest one [...]
http://oxfordclub.com/video/oxf/Healthcare0212.php?code=EOXFN225&n=healthus&o=631457&s=635906&u=27268326&l=393337&g=400&r=Milo Any ideas? Travis? Anybody?
Mark Skousen has spent the past few days touting a stock that’s supposed to skyrocket TODAY — and your friendly neighborhood Gumshoe was busy lolling about over the weekend, so we’re just getting to it now. And don’t worry, the stock is actually down a bit over the last week or so, so if there’s [...]
Marc Lichtenfeld, who we’ve covered a number of times in this space, focuses largely on biotech investments — he’s teased a number of them for a variety of different newsletters that he has helmed or contributed to, but it looks like he’s now launching a new letter from the Oxford Club called FirstLine Investor Alert. [...]
2012 where will the best opportunities to make money this year be? I keep hearing cloud will be the place, I hear the Facebook IPO will be the biggest event for the markets in our lifetime, possibly ever. What I am seeking is more of a macro view of where the market is heading and [...]
I’ll admit right up front that there’s something appealing about this company’s service, at least for your friendly neighborhood Gumshoe … who is a bit more roly-poly than he might like. It’s Hilary Kramer pitching to us again, teasing us that she’s recommending a company that can “freeze the fat away” and that should be [...]
Curing the blind — that sounds lovely, eh? That’s the headline of the latest ad from Patrick Cox … … we’ve seen many overpromising ads from Cox’s Breakthrough Technology Alert over the years, and they never fail to catch the attention of the great Gumshoe readership. It is, after all, just the kind of thing [...]
I thought we might be done for the year … but before we turn out the lights here at Gumshoe HQ for our Christmas week vacation, I couldn’t resist sharing one last teaser tidbit for you — after all, if you’re thinking about what to do with your money next year, what could be better [...]
Hi, I read a mention somewhere of NVIV, They are trying to cure paralysis. I watched this video: http://www.youtube.com/watch?v=mtPwGZ4y428 Luckily, I bought 2000 shares early Monday at 75 cents. Turned out to be a great day. I’m still up 30% for the week. Does anybody here know more about this company? Thanks.
Readers have been avidly forwarding the latest ad from Patrick Cox to me over the past week or so — he’s been pitching his Breakthrough Technology Alert newsletter ($695 “on sale” from the $2,000 “list price”, though as I’ve written about it over the years it’s pretty much always been “on sale”). So naturally, your [...]
“Boobs are just the beginning. “That’s how a national magazine led off an article about the miracle of regenerative medicine. “But it’s not just boobs…” I’ve been seeing lots of questions about an ad that starts with those words, complete with visual aids from Steve Christ in a pitch for his The Wealth Advisory newsletter. [...]
I suppose I should expect this by now — whenever Frank Curzio and the gang put out a teaser for Phase 1 Investor, which is the big-money newsletter from Stansberry & Associates ($5,000/year, though almost always “on sale” at $3,000 when they’re running promos), my inbox gushes like Spindletop. Didn’t matter if it was a [...]
This is all hush-hush, you understand — I’m taking terrible risks by just writing to you today. And my intrepid readers, members of the resistance, have also pushed the limits in sharing this news. The ad makes this very clear — it came with the subject line, “WARNING! Do Not Share, Do Not Forward” But [...]
Today’s little tease comes to us from Hilary Kramer, who I briefly wrote about way back before the Gumshoe Vacation (that was the “Apple Killer,” which inspired a bit of discussion). This time she’s telling us that she’s got a “Cancer Killer” that’s ready to break out — and yes, killing cancer certainly sounds more [...]
Today we look, for a change, at a UK company — this teaser comes in from the folks at Fleet Street Publications (the British partner of our favorite newsletter megalopolis, Agora), in an ad for a letter called Dr. Mike Tubbs’ Research Investments. The letter appears to focus on breakout technology and biotech stocks, with [...]
This is really disappointing. All this time I’ve been under the impression that your friendly neighborhood Stock Gumshoe and his terrifically handsome likeness were all the “female Viagra” the world needed … but apparently some pharmaceutical companies disagree, and have been trying to develop a drug along those lines. At least, that’s the pitch from [...]
Yes, the title of this article is misleading, dangerous crap. Sorry, but I just took it directly from the ad — the ad I’m writing about today is from Patrick Cox for his Breakthrough Technology Alert, a relatively expensive ($895) newsletter that focuses on, well, breakthrough technologies, mostly stocks that we’d classify as biotechs or [...]
This note is very different from what I would write were it entitled, “Front-Running Buffett with David Sokol” — but since he has ended up in the SEC’s crosshairs, and been thrown under the bus by Warren since he made the ridiculously foolish choice to buy shares in a stock he was scouting out as [...]
Oxford Club teaser: ‘Most Hated Industry in America’